Document Library

Click the icons below to search through Pioneer’s reports and documents.

Filename ImpactCOVID-WP.pdf
Filesize 853 KB
Version 1
Date added May 21, 2020
Downloaded 5340 times
Category Health Care, Life Sciences, White Papers

Date: May 21, 2020

Author: William Smith

Contrary to conventional wisdom that says the coronavirus pandemic will generally benefit biopharmaceutical companies, a new Pioneer Institute study finds many companies will emerge from the pandemic commercially weaker, dealing with delays in new product launches and with fewer resources to invest in research and development.